|
46 |
[2020.08.19] CUBEBIO to enter the global market through a rapid non-contact cancer screening
|
2020-08-19 |
|
45 |
[2020.07.02] CUBEBIO entering the living-area market by upgrading a life-friendly device, 'CMDD-04'
|
2020-07-02 |
|
44 |
[2020.06.30] CUBEBIO's subsidiary, FPA, have acquired ISO 13485:2016 for additional production facility.
|
2020-06-30 |
|
43 |
[2020.06.18] CUBEBIO Co., Ltd. develops 'Muti-Channel Automated Diagnostic Device' series for mass screening...Expansion of product lines for overseas export
|
2020-06-18 |
|
42 |
[2020.06.03] CUBEBIO signed a contract to incorporate FPA Co., Ltd., a company specializing in automated equipment development, into its subsidiary
|
2020-06-03 |
|
41 |
[2020.05.25] CUBEBIO, in vitro diagnostic company, awarded the Biotechnology Grand Prize
|
2020-05-25 |
|
40 |
[2020.03.19] CUBEBIO Obtains 'Export Permit' for Urine Diagnosis Medical Devices - 1100 square meters of mass production facility is under construction.
|
2020-03-19 |
|
39 |
[2020.02.28] CUBEBIO receives 'TI-3' rating for investment-type technology assessment, TCB (Technology Credit Bureau), recognized as 'excellent technology'
|
2020-03-09 |
|
38 |
[2020.02.04] CUBEBIO Participated in Arab Health 2020, the largest exhibition in the Middle East, and introduced Cancer Self-Diagnostic Device.
|
2020-02-04 |
|
37 |
[2019.10.18] CUBEBIO attends the World Cancer Leaders' Summit led by the Union for International Cancer Control (UICC)
|
2019-11-05 |